Removing Barriers to Colorectal Cancer Screening Act of 2020
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Removing Barriers to Colorectal Cancer Screening Act of 2020
This bill modifies cost-sharing requirements for colorectal cancer screening tests, and drug manufacturer reporting requirements, under Medicare medical services.
Specifically, the bill waives coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure. The bill phases in implementation over an eight-year period.
Additionally, manufacturers of covered drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Engrossed in House Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Referred in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1570: Removing Barriers to Colorectal Cancer Screening Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-1570/
"H.R. 1570: Removing Barriers to Colorectal Cancer Screening Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-1570/.
H.R. 1570, 116th Cong. (2026), https://openamerica.io/bill/116-HR-1570/.
[H.R. 1570: Removing Barriers to Colorectal Cancer Screening Act of 2020](https://openamerica.io/bill/116-HR-1570/)